Details for New Drug Application (NDA): 207291
✉ Email this page to a colleague
The generic ingredient in SEVELAMER CARBONATE is sevelamer carbonate. There are thirty-two drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the sevelamer carbonate profile page.
Summary for 207291
Tradename: | SEVELAMER CARBONATE |
Applicant: | Macleods Pharms Ltd |
Ingredient: | sevelamer carbonate |
Patents: | 0 |
Pharmacology for NDA: 207291
Mechanism of Action | Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 207291
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SEVELAMER CARBONATE | sevelamer carbonate | FOR SUSPENSION;ORAL | 207291 | ANDA | Macleods Pharmaceuticals Limited | 33342-288 | 33342-288-68 | 90 PACKET in 1 CARTON (33342-288-68) / 1 POWDER, FOR SUSPENSION in 1 PACKET |
SEVELAMER CARBONATE | sevelamer carbonate | FOR SUSPENSION;ORAL | 207291 | ANDA | Macleods Pharmaceuticals Limited | 33342-289 | 33342-289-68 | 90 PACKET in 1 CARTON (33342-289-68) / 1 POWDER, FOR SUSPENSION in 1 PACKET |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 800MG/PACKET | ||||
Approval Date: | Apr 25, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 2.4GM/PACKET | ||||
Approval Date: | Apr 25, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription